ImmVira
PrivateLast Round
Series C
Extension
Oct 26, 2022
Total Funding Raised
$98.5M
Company Overview
ImmVira operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series C Extension round in October 2022.
ImmVira is a biotechnology company that develops novel oncolytic immunotherapies and engineered exosome therapies for the treatment of cancer and other conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmVira Comparables
Compare ImmVira with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing WellGene Biotech Co., Ltd. | 86% | |
| Virogin Biotech | 85% | |
| Guangzhou Virotech Pharmaceutical Co., Ltd. | 84% |
For institutional investors. Book with your work email.
ImmVira Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 26, 2022 | ||||
| Series C | Dec 31, 2020 | ||||
| Series B Extension | Sep 23, 2020 | ||||
| Series B | Jun 15, 2020 | ||||
| Series A Extension | Dec 24, 2018 | ||||
Series A | Aug 18, 2017 |
For institutional investors. Book with your work email.
ImmVira Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series B Extension |
| WinDigital Capital | Series C |
| Hillhouse Investment | Series C, Series A Extension, Series B |
| Triwise Capital | Series A |
| OrbiMed | Series C |
| Yonghua Capital | Series A Extension |
| China Merchants Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2022
Raised $8M led by China Merchants China Direct Investments
- Dec 31, 2020
Raised Series C led by Greater Bay Area Homeland.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 22, 2026
Immvira Co. attends the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, where preliminary Phase IIa data for MVR-T3011 is presented.
- attends_eventOct 22, 2026
Immvira Co. presents clinical data from three bladder cancer studies at ESMO 2026 in Oct '26.
- attends_eventOct 22, 2026
Immvira Co. attends ESMO Congress in 2026.
For institutional investors. Book with your work email.
ImmVira Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmVira's valuation, stock price, and market status.
Is ImmVira a public or private company?
ImmVira is a private company.
What is the current stock price of ImmVira?
ImmVira is a private company, so its shares have no public market price. Caplight tracks ImmVira's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmVira worth (valuation)?
Valuation information for ImmVira is not publicly available.
Can I buy ImmVira stock?
ImmVira shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmVira's last funding round?
ImmVira's most recent funding round was Series C Extension on October 26, 2022.
Who are the main investors in ImmVira?
Key investors in ImmVira include Shanghai Healthcare Capital, Triwise Capital, China Merchants China Direct Investments, Huagai Capital, Greater Bay Area Homeland.
Will ImmVira IPO soon?
No public IPO plans have been announced for ImmVira.
How can I track ImmVira secondary market activity?
Caplight tracks bids, offers, and trades in ImmVira's shares on secondary markets.